MD Anderson

the largest long-term-survival clinical datasets.

Country: United States

NCI Cancer Center

Coverage

	CN	EU	US
therapeutics-platforms	✓	✓	✓

Regulatorsfdaemanmpa

Verifiable facts

Fact	Value	Source
Affiliation	The University of Texas System	cancer.gov · ebsco.com · mdanderson.org
Research focus	cancer patient care, research, education and prevention	ebsco.com · mdanderson.org
Facility	Numerous centers and institutes including the Institute for Data Science in Oncology, Center for Advanced Biomedical Imaging, and Proton Therapy Center	mdanderson.org
Grant	National Cancer Institute (NCI) grants and Cancer Prevention Research Institute of Texas (CPRIT) funding	ebsco.com · mdanderson.org
Publications	140+ patents awarded (FY25)	cancer.gov · mdanderson.org
Principal staff	Includes departmental chairs, faculty, biostatisticians, and research administrators	mdanderson.org
Headcount	Approximately 25,000 to 27,000 employees, including over 2,000 faculty	cancer.gov · ebsco.com · mdanderson.org

Independent sources: cancer.gov · ebsco.com

Technologies

Name	Cluster	Risk
NK-cell & CAR-NK therapy	therapeutics-platforms	Medium	→
TIL therapy (tumor-infiltrating lymphocytes)	therapeutics-platforms	Medium	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.